DXR Daxor Corporation - Closed End Fund

NASDAQ · Health Care · View on SEC EDGAR ↗
$11.36
Price · May 19, 2026
Fundamentals as of Mar 28, 2012
52W Range
$7–$15
54% of range
Analyst Rating
BUY
6 analysts
Price Target
$22
+98% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—

DXR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$11.36
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$7 – $15

DXR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
2-point trend, -8.4%
2010-12-31 → 2011-12-31
EPS —
Free Cash Flow —
2011-12-31 → 2011-12-31
Margins —
2011-12-31 → 2011-12-31

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
DXR
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
DXR
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
DXR
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
DXR
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
DXR
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
DXR
Peer Median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

Dividend Yield
—
Payout Ratio
—
5Y Div CAGR
—
Ex-dateAmount
Jan. 5, 2018$0.0300
Dec. 20, 2016$0.0300
Dec. 18, 2015$0.0400
Dec. 4, 2014$0.0300
Dec. 5, 2013$0.0500
Dec. 7, 2012$0.1000
Aug. 10, 2012$0.1000
Nov. 16, 2011$0.1000
May 27, 2011$0.1500
Dec. 14, 2010$0.6500
Sept. 13, 2010$0.2500
May 27, 2010$0.1000
Dec. 8, 2009$1.0000
Aug. 21, 2009$0.2500
May 27, 2009$0.1000
Dec. 10, 2008$1.0000
Oct. 31, 2008$0.2500
July 24, 2008$0.2500
April 28, 1998$0.1250
April 28, 1997$0.5000

DXR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 6 analysts
  • Strong Buy 1 16.7%
  • Buy 4 66.7%
  • Hold 1 16.7%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

2 analysts · 2026-05-19
Median target $22.50 +98.1%
Mean target $22.50 +98.1%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.39%
Period EPS Actual EPS Est Surprise
Sept. 30, 2007 $0.43 $0.10 0.33%
June 30, 2007 $0.51 $0.01 0.50%
March 31, 2007 $0.66 $-0.03 0.69%
Dec. 31, 2006 $0.01 $-0.02 0.03%

Peer Comparison Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
DXR — — — — — —
VANI $94M -2.9 — — -257.8% —
MDAI — — — — — —
OM $67M -0.7 5.1% -68.3% -58.0% 39.1%
LNSR — -4.1 9.2% — — —
QTI $73M -3.0 287.9% -111.4% -688.9% 45.4%
LUNG $92M -1.7 8.0% -59.7% -87.7% 74.2%
POCI — -5.8 -0.07% — — —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 11
Annual Income Statement data for DXR
Metric Trend 20112010
Revenue 2-point trend, -8.4% $1M $2M
Cost of Revenue 2-point trend, -10.3% $652.5K $727.6K
Gross Profit 2-point trend, -6.8% $793.8K $851.6K
R&D Expense 2-point trend, -11.0% $3M $3M
SG&A Expense 2-point trend, +11.7% $4M $3M
Operating Expenses 2-point trend, +1.1% $7M $7M
Operating Income 2-point trend, -2.2% $-6M $-6M
Other Non-op 2-point trend, -173.9% $-168.9K $-61.7K
Income Tax 2-point trend, -252.0% $-5M $3M
Net Income 2-point trend, -244.6% $-7M $5M
EBITDA $-6M ·
Balance Sheet 20
Annual Balance Sheet data for DXR
Metric Trend 20112010
Cash & Equivalents 2-point trend, +3.3% $59.6K $57.7K
Short-term Investments 2-point trend, +3.6% $56M $54M
Receivables 2-point trend, +22.9% $219.7K $178.8K
Inventory 2-point trend, -17.1% $301.5K $363.6K
Prepaid Expense 2-point trend, +60.3% $209.3K $130.6K
Current Assets 2-point trend, -6.1% $82M $87M
PP&E (Net) 2-point trend, -4.0% $4M $4M
Other Non-current Assets Flat — no change across 2 periods $37.2K $37.2K
Total Assets 2-point trend, -6.0% $86M $91M
Accounts Payable 2-point trend, +20.3% $525.2K $436.5K
Current Liabilities 2-point trend, +12.2% $49M $44M
Total Liabilities 2-point trend, +12.0% $50M $44M
Common Stock Flat — no change across 2 periods $53.2K $53.2K
Paid-in Capital 2-point trend, +0.1% $11M $11M
Retained Earnings 2-point trend, -25.0% $25M $33M
Treasury Stock 2-point trend, +2.0% $12M $12M
AOCI 2-point trend, -15.6% $13M $15M
Stockholders' Equity 2-point trend, -22.9% $36M $47M
Liabilities + Equity 2-point trend, -6.0% $86M $91M
Shares Outstanding 2-point trend, -0.6% 4,202,351 4,226,137
Cash Flow 10
Annual Cash Flow data for DXR
Metric Trend 20112010
Stock-based Comp $9.7K ·
Deferred Tax 2-point trend, +106.1% $1M $606.4K
Operating Cash Flow 2-point trend, -14.4% $-7M $-6M
CapEx 2-point trend, -62.1% $123.2K $324.7K
Investing Cash Flow 2-point trend, -221.1% $-11M $9M
Dividends Paid 2-point trend, -75.1% $1M $4M
Financing Cash Flow 2-point trend, +555.3% $18M $-4M
Net Change in Cash 2-point trend, +100.9% $1.9K $-219.3K
Taxes Paid 2-point trend, +23.8% $3M $2M
Free Cash Flow $-7M ·
Profitability 6
Annual Profitability data for DXR
Metric Trend 20112010
Gross Margin 54.9% ·
Operating Margin -400.1% ·
Net Margin -496.8% ·
EBITDA Margin -400.1% ·
ROA -8.1% ·
ROE -17.3% ·
Liquidity & Solvency 2
Annual Liquidity & Solvency data for DXR
Metric Trend 20112010
Current Ratio 1.7 ·
Quick Ratio 1.1 ·
Efficiency 3
Annual Efficiency data for DXR
Metric Trend 20112010
Asset Turnover 0.0 ·
Inventory Turnover 2.0 ·
Receivables Turnover 7.3 ·
Per Share 3
Annual Per Share data for DXR
Metric Trend 20112010
Book Value / Share $8.62 ·
Cash / Share $0.01 ·
Dividend Paid / Share 2-point trend, -75.0% $0 $1
Valuation (TTM) 10
Annual Valuation (TTM) data for DXR
Metric Trend 20112010
Revenue TTM 2-point trend, -8.4% $1M $2M
Net Income TTM 2-point trend, -244.6% $-7M $5M
Market Cap $38M ·
P/S 26.4 ·
P/B 1.1 ·
P / Cash Flow -5.9 ·
P / FCF -5.8 ·
Dividend Yield 2.8% ·
Payout Ratio -14.7% ·
Annual Payout 2-point trend, -75.1% $1M $4M

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2011-12-312010-12-31
Revenue $1M$2M
Gross Margin % 54.9%—
Operating Margin % -400.1%—
Net Income $-7M$5M
Balance Sheet
2011-12-312010-12-31
Current Ratio 1.7—
Quick Ratio 1.1—
Cash Flow
2011-12-312010-12-31
Free Cash Flow $-7M—

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.